ADDED
false --09-30 FY 2025 To mitigate the threat to our business, we take a comprehensive approach to cybersecurity risk management.
9,419,410 shares of common stock are issued and outstanding as of December 16, 2025.
In addition, "fiscal 2024" refers to the year ended September 30, 2024, and fiscal 2025 refers to the year ended September 30, 2025.
material risks associated with the ownership of our securities, including; the risks for failing to comply with the continued listing standards of the NYSE American; availability of sufficient liquidity; the designations, rights and preferences of our Series B Convertible Preferred Stock; and dilution upon the issuance of shares of common stock underlying outstanding warrants, options and the Series B Convertible Preferred Stock.
is a consumer wellness company focused on the development, manufacturing, marketing, and sale of supplement brands powered by natural compounds.
The majority of our products are anchored by hemp-derived cannabinoids, including broad-spectrum and full-spectrum CBD formulations, hemp-derived Delta-9 THC products (where permitted by law), and a range of functional products designed to address key wellness needs such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management.
Our approach centers on combining scientific rigor with high manufacturing standards to produce consistent, safe, and reliable products that meet both consumer expectations and evolving regulatory requirements.
We operate a multi-brand portfolio anchored by our flagship cbdMD line, which offers oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products.
Complementing this portfolio is Paw CBD , our dedicated pet-wellness brand, which provides tinctures, chews, and topicals for dogs and cats and reflects our long-standing emphasis on safety and quality in the animal health category.
Our ATRX platform offers cutting edge, emerging and novel non-cannabinoid functional ingredients such as functional mushrooms and supports future expansion into performance-driven nutraceutical and nootropic categories utilizing synergistic ingredient combinations.
REMOVED
5,539,124 shares of common stock are issued and outstanding as of December 16, 2024.
In addition, "fiscal 2023" refers to the year ended September 30, 2023, and fiscal 2024 refers to the year ended September 30, 2024.
DESCRIPTION OF BUSINESS Our Company General We own and operate the nationally recognized CBD (cannabidiol) brands cbdMD and Paw CBD as well as our ATRx Labs brand of functional mushrooms.
We believe that we are an industry leader producing and distributing dietary supplements and topical products, with an initial focus on hemp derived products including broad spectrum CBD products and full spectrum CBD products.
Our mission is to identify and formulate products with novel, compelling ingredients and blends to enhance our customer s overall quality of life while bringing education, awareness and accessibility of high quality and effective products to all.
Our innovative broad spectrum formula utilizes a clinically studied hemp extract blend, containing CBD, CBG and CBN, while eliminating the presence of tetrahydrocannabinol (THC).
Our full spectrum and Delta 9 products contain a variety of cannabinoids and terpenes while maintaining small amounts of THC that fall within the limits set in the 2018 Farm Act.
The ATRx brand was launched to bring non cannabinoid products to market, starting with non-psychoactive functional dietary mushrooms such as Lion s Mane, Cordyceps and Reshi.
In addition to our core brands, we also operate Therapeutics to capture the Company s ongoing investments in science related to its existing and future products, including research and development activities for therapeutic applications and Proline Global that houses some of our newer brands.
Our cbdMD brand of products includes an array of high-grade, premium every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixers and ready to drink cans; and sleep, focus and calming aids.